XEN-393

N/A

Report date: 2024/02/02 17:53:30
NME

Base Information

Drug NameXEN-393
Drug Alias NameXEN-393
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type VIII alpha subunit inhibitorsSodium channel protein type II alpha subunit inhibitors
TargetsSodium channel protein type VIII alpha subunitSodium channel protein type II alpha subunit
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences IncXenon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A